Back to mobile site

GoodRx (GDRX) named Best Smidcap Idea at TD Cowen

June 10, 2024 5:30 AM EDT Send to a Friend
TD Cowen analyst Charles Rhyee reiterated a Buy rating and $16.00 price target on GoodRx Holdings Inc. (NASDAQ: GDRX) and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login